Ferroptosis is linked to depression by suppressing BDNF expression, while gut microorganisms influence BDNF and modulate depression through the brain-gut axis (Matin and Dadkhah, 2024)
The practice takes a functional-medicine approach to peptide therapy, pairing BPC, GLP-1, and GHK-Cu with multi-route administration
Central to this network is the mitochondria-ER-lysosome axis (MELA), which integrates metabolic and redox signals to amplify ferroptosis, rendering it a critical target for therapeutic intervention
These improvements occur both from weight loss itself and from the medication's direct effects on metabolic health
Starting weight, body fat percentage, training history, hormonal status, sleep quality, stress levels, and dose all create different timelines
Haemochromatosis genotypes and incident dementia in a prospective study of older adults